Litcius/Paper detail

Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate

Hui‐Chao Ma, Gong-Jun Chen, Fang Huang, Yu‐Bin Dong

2020Journal of the American Chemical Society117 citationsDOI

Abstract

(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetonitrile ((S)-CIK) is a key intermediate in the synthesis of (S)-clopidogrel, which is one of the most saleable worldwide antiplatelet and antithrombotic drugs. We show herein a facile method for the direct synthesis of (S)-CIK via Strecker reaction using a homochiral covalent framework catalyst in a heterogeneous way. The asymmetric synthesis involves a photothermal-conversion-triggered, thermally driven reaction which affords (S)-CIK in 98% yield with 94% enantiomeric excess under visible-light irradiation. Furthermore, the above approach is readily extended to a gram-scale level on a fixed-bed continuous-flow model reactor. The potential utility of this strategy is highlighted by the preparation of many more other types of chiral drugs and drug intermediates in a green and facile way.

Topics & Concepts

ChemistryCatalysisCovalent bondEnantioselective synthesisCombinatorial chemistryEnantiomerAcetonitrileYield (engineering)Enantiomeric excessOrganic synthesisAntithromboticOrganic chemistryMedicineMetallurgyCardiologyMaterials scienceCovalent Organic Framework ApplicationsAdvanced Photocatalysis TechniquesMetal-Organic Frameworks: Synthesis and Applications
Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate | Litcius